Small airways disease in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Respiratory Research

Background:

• Small airway disease (SAD) is a critical component of Chronic Obstructive Pulmonary Disease (COPD).
• Chronic exposure to irritants like smoking causes inflammation and remodeling, leading to SAD and airway obstruction.
• SAD is increasingly recognized as a primary site for COPD's onset and progression.

Purpose of the Study:

• To provide a comprehensive analysis of current literature on SAD in COPD.
• To focus on pathophysiological mechanisms, diagnostic techniques, and pharmacological treatments for small airway obstruction.
• To highlight the importance of early SAD identification in COPD management.

Main Methods:

• Literature search conducted in PubMed up to June 2024.
• Inclusion of articles on SAD and airway diseases, primarily COPD.
• Focus on studies relevant to uncontrolled/severe asthma where SAD is well-studied.

Main Results:

• Small airways are central to airflow obstruction in COPD patients.
• SAD significantly impacts lung function, causes hyperinflation, and reduces quality of life.
• Early detection of subclinical SAD can prevent disease advancement and emphysema development.

Conclusions:

• Early identification of SAD in COPD is vital for timely therapeutic intervention.
• Understanding SAD mechanisms and diagnostics is crucial for managing airflow obstruction.
• Targeting small airways offers potential for improved COPD treatment strategies.